Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-10 to 2023-01-11
Current total value of award: $48082.26
Description: 4559600583!REBLOZYL 75 MG VIALS